Viewing Study NCT01200758


Ignite Creation Date: 2025-12-25 @ 12:03 AM
Ignite Modification Date: 2025-12-25 @ 10:01 PM
Study NCT ID: NCT01200758
Status: COMPLETED
Last Update Posted: 2018-11-27
First Post: 2010-09-10
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: A Study of Rituximab (MabThera) Subcutaneous (SC) Versus Rituximab (MabThera) Intravenous in Participannts With Follicular Non-Hodgkin's Lymphoma
Sponsor: Hoffmann-La Roche
Organization: